Kenya’s adoption of long-acting injectable lenacapavir is a major HIV prevention breakthrough, but its success will depend on public trust and dignity in delivery.

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

A suspected bio lab located inside a Las Vegas garage contained materials to create test kits, compounds for Influenza ...

How people with compromised immune systems respond to vaccines is an important area of immunological research. A new study led by York University found that not only could machine-learning models ...

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Introduction: HIV self-testing (HIVST) is an innovative strategy that has been shown to increase uptake of HIV testing compared to conventional facility-based testing. HIVST implementation with ...

Scientists at Gladstone Institutes, in collaboration with a team at the San Francisco Veterans Affairs Medical Center, have developed a novel tool—named HIV-seq—for profiling the features of rare ...

It’s high time to change this and focus on sexual and reproductive health for men. Every single unplanned pregnancy involves ...

Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.